Urine Albumin-to-Creatinine Ratio in Restless Legs Syndrome
Checking urine albumin-to-creatinine ratio (ACR) in patients with Restless Legs Syndrome (RLS) is important primarily to screen for chronic kidney disease (CKD), which is a common secondary cause of RLS and significantly impacts mortality and morbidity outcomes.
Connection Between RLS and Kidney Disease
Kidney disease, particularly end-stage renal disease (ESRD), is strongly associated with RLS for several reasons:
- Uremic RLS (RLS secondary to kidney disease) has a much higher prevalence (12-62%) compared to the general population (3-9%) 1
- RLS in dialysis patients is associated with:
Why Check ACR Specifically
Early Detection of Kidney Disease:
Staging and Risk Assessment:
Treatment Implications:
Clinical Approach to ACR Testing in RLS
When to Check ACR in RLS Patients:
- At initial evaluation of all patients with RLS symptoms 3
- Particularly important in patients with:
Interpreting ACR Results:
- Normal ACR: <30 mg/g creatinine 4
- Moderately increased: 30-299 mg/g creatinine 4
- Severely increased: >300 mg/g creatinine 4
Management Implications:
- If ACR is elevated:
Clinical Significance
The presence of albuminuria in RLS patients has significant implications:
Mortality Risk: RLS patients with kidney disease have significantly higher mortality (up to 55.6% in those with continuous RLS symptoms) 1
Cardiovascular Risk: RLS with kidney disease increases cardiovascular event risk by 64.5% compared to 39.1% in those without RLS 1
Treatment Resistance: Uremic RLS often requires higher medication doses and has decreased response to dopaminergic agonists 2
Disease Progression: Uremic RLS deteriorates faster and becomes more severe than idiopathic RLS 2
By identifying kidney disease through ACR testing in RLS patients, clinicians can implement appropriate treatment strategies that address both conditions and potentially reduce mortality and morbidity risks.